TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges

E-ISSN： 1876-1038|4|1|34-41

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.4, Iss.1, 2009-01, pp. : 34-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials of Targeted Alpha Therapy for Cancer

Reviews on Recent Clinical Trials, Vol. 3, Iss. 3, 2008-09 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Therapy of Metastatic Breast Cancer: The Truth Beyond the Clinical Trials

Oncology, Vol. 76, Iss. 4, 2009-02 ,pp. : 247-253

Karger

Access to resources Recommend Favorite

Clinical Trials of Poly(ADP-Ribose) Polymerase Inhibitors for Cancer Therapy: A Review

Reviews on Recent Clinical Trials, Vol. 10, Iss. 4, 2015-12 ,pp. : 326-339

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of CAR- or CD46-Dependent Adenoviral Vector-Mediated TRAIL Gene Therapy in Clinical Adenocarcinoma Lung Cancer Cells

Oncology, Vol. 77, Iss. 6, 2010-01 ,pp. : 366-377

Karger

Access to resources Recommend Favorite

Promises and challenges of the first clinical-grade induced pluripotent stem cell bank

By Ilic Dusko Stephenson Emma

Regenerative Medicine, Vol. 8, Iss. 2, 2013-03 ,pp. : 101-102

Future Medicine

Access to resources Recommend Favorite